Boston University Begins SPARX3 Trial for People with Parkinson’s
The Boston University Department of Physical Therapy & Athletic Training and the Parkinson’s Disease Movement Disorders Center at Boston University Medical Campus are excited to begin recruitment for the Study in Parkinson’s Disease of Exercise Phase 3 Clinical Trial (SPARX3). This NIH-funded study seeks to learn more about the effects of aerobic exercise on people with Parkinson’s disease.
To learn more about this study and its eligibility requirements, see a flyer here.
Contact Mike Stevenson, 617-638-7747 or msteven1@bu.edu, if you are interested in participating.